Скачать или смотреть Unlocking Innovations: Stay Current with the Latest in Ovarian Cancer Management Updates

CRI’s Cancer Immunotherapy and You™ Patient Education Webinar Series returns with its latest offering: Unlocking Innovations: Stay Current with the Latest in Ovarian Cancer Management Updates.

Featuring Dimitriy Zamarin, MD, PhD, Professor of Hematology/Oncology, Section Chief of Gynecologic Medical Oncology, a leading expert at the Precision Immunology Institute and Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai in New York, and CRI Clinical Accelerator Investigator, this webinar dives into the latest developments in ovarian cancer.

Join Dr. Zamarin as he provides crucial insights into ovarian cancer — from understanding different types, exploring risk factors, and emphasizing the importance of early detection. He also covers how advancements in diagnostic tools and genetic testing are shaping more targeted and effective treatments. Additionally, Dr. Zamarin highlights the latest breakthroughs in immunotherapy and ongoing clinical trials that could redefine the future of ovarian cancer treatment.

This webinar offers a comprehensive look at personalized treatment plans, survivorship care, and the support available to both patients and caregivers. You will also hear about the potential side effects of immunotherapy, inspiring success stories, and practical guidance for accessing new therapies. Whether you are a patient, caregiver, or are simply looking to learn more, this webinar provides invaluable information to support your journey.
--
Established in 1953, the Cancer Research Institute (CRI) is a 501(c)(3) nonprofit organization dedicated to harnessing our immune system’s power to control and potentially cure all cancers. Our mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. To accomplish this, we rely on donor support and collaborative partnerships to fund and carry out the most innovative clinical and laboratory research around the world, support the next generation of the field’s leaders, and serve as the trusted source of information on immunotherapy for cancer patients and their caregivers. https://www.cancerresearch.org

Cancer Research Institute is a registered 501(c)(3) nonprofit under EIN 13-1837442. Donations are tax-deductible to the fullest extent allowable under the law.